Sage Journals: Discover world-class research

Retricted access

Case report

First published 2025-2

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor-Related Euglycemic Diabetic Ketoacidosis: A Case Series

Mackenzi Meier, Benedicta Ansong, Dolapo Awobusuyi [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2024-12

Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge

Emily Wo, Cara Trulli, Jessica Wilczynski [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2022-05-17

Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes

Serena Low, Kiat Sern Goh, Tze Pin Ng [...]

Journal of Alzheimer’s Disease

Free access

Review article

First published 2018-1

Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential

Michael E. Røder

Sage Open Chronic Disease

Open access

Review article

First published 2025-03

Comparison Between SGLT2 Inhibitors and Lactation: Implications for Cardiometabolic Health in Parous Women

Maria A. Ramos-Roman

Metabolic Syndrome and Related Disorders

Free access

Research article

First published 2015-3

Development of sotagliflozin,a dual sodium-dependent glucose transporter 1/2 inhibitor

Pablo Lapuerta, Brian Zambrowicz, Paul Strumph [...]

Diabetes & Vascular Disease Research

Free access

Review article

First published 2016-12

The renal effects of SGLT2 inhibitors and a mini-review of the literature

Vasileios Andrianesis, Spyridoula Glykofridi, John Doupis

Therapeutic Advances in Endocrinology and Metabolism

Free access

Research article

First published 2015-3

Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences

Linda A Gallo, Ernest M Wright, Volker Vallon

Diabetes & Vascular Disease Research

Retricted access

Review article

First published 2024-5

A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes

Kevin Cowart, Scott Coon, Nicholas W. Carris

Annals of Pharmacotherapy

Open access

Review article

First published 2024

Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review

Afif Nakhleh, Jomana Mazareeb, Said Darawshi [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Search results